BD (NYSE:BDX) announced today that it acquired Venclose and its solutions for treating chronic venous insufficiency (CVI). CVI occurs as the result of malfunctioning valves and can lead to varicose veins. Venclose’s CVI treatment uses radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain and bruising compared to alternative laser treatment therapy. […]
venclose
Venclose closes $27m Series C
Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. The San Jose, Calif.–based company said that, after securing the $27 million, it […]
Venous reflux cath dev Venclose closes oversubscribed Series B
Venous reflux disease treatment developer Venclose said this week it closed an oversubscribed Series B round of financing, but did not disclose the amount raised. The San Jose, Calif.-based company said that the round was joined by new and existing investors, and that proceeds from the round will help support new product development, manufacturing expansion […]
